Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 16
2004 8
2005 8
2006 12
2007 17
2008 14
2009 16
2010 23
2011 23
2012 12
2013 21
2014 20
2015 9
2016 15
2017 15
2018 14
2019 12
2020 25
2021 23
2022 21
2023 25
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

333 results

Results by year

Filters applied: . Clear all
Page 1
Follikulotropismus bei Lentigo maligna und Lentigo-maligna-Melanom im Kopf-Hals-Bereich.
Dika E, Lambertini M, Patrizi A, Misciali C, Scarfì F, Pellacani G, Mandel VD, Tullio FD, Stanganelli I, Chester J, Kaleci S, Massi D, De Giorgi V, Cinotti E, Rubegni P, Perrot JL, Farnetani F. Dika E, et al. Among authors: massi d. J Dtsch Dermatol Ges. 2021 Feb;19(2):223-230. doi: 10.1111/ddg.14311_g. J Dtsch Dermatol Ges. 2021. PMID: 33586901 German.
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
Landi MT, Bishop DT, MacGregor S, Machiela MJ, Stratigos AJ, Ghiorzo P, Brossard M, Calista D, Choi J, Fargnoli MC, Zhang T, Rodolfo M, Trower AJ, Menin C, Martinez J, Hadjisavvas A, Song L, Stefanaki I, Scolyer R, Yang R, Goldstein AM, Potrony M, Kypreou KP, Pastorino L, Queirolo P, Pellegrini C, Cattaneo L, Zawistowski M, Gimenez-Xavier P, Rodriguez A, Elefanti L, Manoukian S, Rivoltini L, Smith BH, Loizidou MA, Del Regno L, Massi D, Mandala M, Khosrotehrani K, Akslen LA, Amos CI, Andresen PA, Avril MF, Azizi E, Soyer HP, Bataille V, Dalmasso B, Bowdler LM, Burdon KP, Chen WV, Codd V, Craig JE, Dębniak T, Falchi M, Fang S, Friedman E, Simi S, Galan P, Garcia-Casado Z, Gillanders EM, Gordon S, Green A, Gruis NA, Hansson J, Harland M, Harris J, Helsing P, Henders A, Hočevar M, Höiom V, Hunter D, Ingvar C, Kumar R, Lang J, Lathrop GM, Lee JE, Li X, Lubiński J, Mackie RM, Malt M, Malvehy J, McAloney K, Mohamdi H, Molven A, Moses EK, Neale RE, Novaković S, Nyholt DR, Olsson H, Orr N, Fritsche LG, Puig-Butille JA, Qureshi AA, Radford-Smith GL, Randerson-Moor J, Requena C, Rowe C, Samani NJ, Sanna M, Schadendorf D, Schulze HJ, Simms LA, Smithers M, Song F, Swerdlow AJ, van der S… See abstract for full author list ➔ Landi MT, et al. Among authors: massi d. Nat Genet. 2020 May;52(5):494-504. doi: 10.1038/s41588-020-0611-8. Epub 2020 Apr 27. Nat Genet. 2020. PMID: 32341527 Free PMC article.
ESP, EORTC, and EURACAN Expert Opinion: practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variants.
de la Fouchardiere A, Blokx W, van Kempen LC, Luzar B, Piperno-Neumann S, Puig S, Alos L, Calonje E, Massi D; ESP Dermatopathology Working Group; EORTC Melanoma Group; EURACAN. de la Fouchardiere A, et al. Among authors: massi d. Virchows Arch. 2021 Jul;479(1):3-11. doi: 10.1007/s00428-020-03005-1. Epub 2021 Jan 12. Virchows Arch. 2021. PMID: 33432480
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.
Barnhill RL, Elder DE, Piepkorn MW, Knezevich SR, Reisch LM, Eguchi MM, Bastian BC, Blokx W, Bosenberg M, Busam KJ, Carr R, Cochran A, Cook MG, Duncan LM, Elenitsas R, de la Fouchardière A, Gerami P, Johansson I, Ko J, Landman G, Lazar AJ, Lowe L, Massi D, Messina J, Mihic-Probst D, Parker DC, Schmidt B, Shea CR, Scolyer RA, Tetzlaff M, Xu X, Yeh I, Zembowicz A, Elmore JG. Barnhill RL, et al. Among authors: massi d. JAMA Netw Open. 2023 Jan 3;6(1):e2250613. doi: 10.1001/jamanetworkopen.2022.50613. JAMA Netw Open. 2023. PMID: 36630138 Free PMC article.
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux.
O'Donnell JS, Massi D, Teng MWL, Mandala M. O'Donnell JS, et al. Among authors: massi d. Semin Cancer Biol. 2018 Feb;48:91-103. doi: 10.1016/j.semcancer.2017.04.015. Epub 2017 May 2. Semin Cancer Biol. 2018. PMID: 28467889 Review.
Melanoma on congenital melanocytic nevi.
Alos L, Carrasco A, Teixidó C, Szumera-Ciećkiewicz A, Vicente A, Massi D, Carrera C. Alos L, et al. Among authors: massi d. Pathol Res Pract. 2024 Apr;256:155262. doi: 10.1016/j.prp.2024.155262. Epub 2024 Mar 11. Pathol Res Pract. 2024. PMID: 38518732 Review.
Basal-cell carcinoma.
De Giorgi V, Massi D, Lotti T. De Giorgi V, et al. Among authors: massi d. N Engl J Med. 2006 Feb 16;354(7):769-71; author reply 769-71. doi: 10.1056/NEJMc053488. N Engl J Med. 2006. PMID: 16481651 No abstract available.
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, Antonuzzo L, Supuran CT, Olivo E, Pasqualini E, Messerini L, Massi D, Lulli M, Ruzzolini J, Peppicelli S, Bianchini F, Schiavone N, Calorini L, Magnelli L, Papucci L. Andreucci E, et al. Among authors: massi d. Cancer Lett. 2023 Sep 1;571:216338. doi: 10.1016/j.canlet.2023.216338. Epub 2023 Aug 6. Cancer Lett. 2023. PMID: 37549770
333 results